Work

A Dual Phase I/II Study of th-302 and Bevacizumab in Resectable Recurrent Glioblastoma Following Bevacizumab Failure

Year: 2012

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1016/s0923-7534(20)32995-1

Authors: R.M. Zuniga, J. Sun, J.R. Floyd, S.R. Yerragudi, C. Hart, C. Eng, A.J. Brenner

Institutions: The University of Texas at San Antonio Health Science Center, Threshold Pharmaceuticals (United States)

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2999441790

FWCI:

Cites:

Cited by:

Related to: 10